Literature DB >> 10466659

Meningococcal conjugate vaccines: new opportunities and new challenges.

M C Maiden1, B G Spratt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10466659     DOI： 10.1016/s0140-6736(99)00252-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  24 in total

Review 1.  Vaccine trials.

Authors:  C P Farrington; E Miller
Journal:  Mol Biotechnol       Date:  2001-01       Impact factor: 2.695

2.  Laboratory confirmation of meningococcal disease in Scotland, 1993-9.

Authors:  S C Clarke; J Reid; L Thom; B C Denham; G F S Edwards
Journal:  J Clin Pathol       Date:  2002-01       Impact factor: 3.411

3.  Meningococcal group C conjugate vaccines.

Authors:  J Maclennan
Journal:  Arch Dis Child       Date:  2001-05       Impact factor: 3.791

4.  Identification of Neisseria meningitidis serogroups Y and W135 by siaD nucleotide sequence analysis.

Authors:  C Lewis; S C Clarke
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

Review 5.  Reprogramming the host response in bacterial meningitis: how best to improve outcome?

Authors:  M van der Flier; S P M Geelen; J L L Kimpen; I M Hoepelman; E I Tuomanen
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

6.  Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway.

Authors:  Siamak P Yazdankhah; Paula Kriz; Georgina Tzanakaki; Jenny Kremastinou; Jitka Kalmusova; Martin Musilek; Torill Alvestad; Keith A Jolley; Daniel J Wilson; Noel D McCarthy; Dominique A Caugant; Martin C J Maiden
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

7.  Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity.

Authors:  Martin C J Maiden; Ana Belén Ibarz-Pavón; Rachel Urwin; Stephen J Gray; Nicholas J Andrews; Stuart C Clarke; A Mark Walker; Meirion R Evans; J Simon Kroll; Keith R Neal; Dlawer A A Ala'aldeen; Derrick W Crook; Kathryn Cann; Sarah Harrison; Richard Cunningham; David Baxter; Edward Kaczmarski; Jenny Maclennan; J Claire Cameron; James M Stuart
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

Review 8.  Meningococcal vaccines.

Authors:  Jens U Rüggeberg; Andrew J Pollard
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

9.  Clonal groupings in serogroup X Neisseria meningitidis.

Authors:  Sébastien Gagneux; Thierry Wirth; Abraham Hodgson; Ingrid Ehrhard; Giovanna Morelli; Paula Kriz; Blaise Genton; Tom Smith; Fred Binka; Gerd Pluschke; Mark Achtman
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883

10.  Influence of two vaccination campaigns on genetic diversity of invasive Neisseria meningitidis isolates in northern Spain (1997-2008).

Authors:  Diego Vicente; Olatz Esnal; M José López de Goicoechea; Ramón Cisterna; Emilio Pérez-Trallero
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.